Alison Armour
Corporate Officer/Principal chez Royal College of Physicians & Surgeons of Glasgow
Profil
Actuellement, Alison A. Armour occupe le poste de vice-présidente directrice de la recherche et du développement chez Halozyme Therapeutics, Inc. Le Dr Armour est également membre du Royal College of Physicians & Surgeons of Glasgow. Le Dr Armour a précédemment occupé le poste de vice-président de l'oncologie chez GlaxoSmithKline Plc, de vice-président de l'oncologie chez Novartis AG et de directeur médical d'Endocyte, Inc. (une filiale de Novartis AG) et directeur des sciences médicales mondiales chez AstraZeneca Plc. Alison A. Armour a obtenu un diplôme de premier cycle, un diplôme d'études supérieures et un doctorat de l'université de Glasgow.
Postes actifs de Alison Armour
Sociétés | Poste | Début |
---|---|---|
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Corporate Officer/Principal | - |
Anciens postes connus de Alison Armour
Sociétés | Poste | Fin |
---|---|---|
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2020 |
NOVARTIS AG | Corporate Officer/Principal | 01/07/2015 |
GSK PLC | Corporate Officer/Principal | 01/07/2015 |
ASTRAZENECA PLC | Corporate Officer/Principal | 01/08/2011 |
ENDOCYTE, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Alison Armour
University of Glasgow | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 4 |
---|---|
ASTRAZENECA PLC | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
NOVARTIS AG | Health Technology |
GSK PLC | Health Technology |
Entreprise privées | 2 |
---|---|
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Royal College of Physicians & Surgeons of Glasgow
Royal College of Physicians & Surgeons of Glasgow Other Consumer ServicesConsumer Services The Royal College of Physicians and Surgeons of Glasgow is a multidisciplinary organization that sets standards of care for the prevention and treatment of sickness and trauma in travelers. The British company has published a good practice guide for providing a travel health service, which defines the standards of care every practitioner should achieve in their practice of travel medicine for the health and safety of the international traveler. The organization offers a wide range of membership benefits and discounts on clinical and non-clinical skills courses, conferences, and e-learning. The private company also provides examinations and assessments across medical, surgical, and dental specialties to advance the profession and improve patient care through continuing professional development. | Consumer Services |